We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$15B
AUM Growth
+$614M
Cap. Flow
-$689M
Cap. Flow %
-4.6%
Top 10 Hldgs %
9.86%
Holding
499
New
33
Increased
63
Reduced
287
Closed
34

Top Sells

Rank Stock Value
1
PODD icon
Insulet
PODD
+$86.4M
2
SAGE
Sage Therapeutics
SAGE
+$56.2M
3
WEC icon
WEC Energy
WEC
+$49.5M
4
AOS icon
A.O. Smith
AOS
+$48.9M
5
CHRW icon
C.H. Robinson
CHRW
+$41.8M

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Healthcare 17.37%
3 Industrials 15.16%
4 Consumer Discretionary 13.51%
5 Financials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACAD icon
176
Acadia Pharmaceuticals
ACAD
$4.51B
$30.6M 0.2%
715,382
MRK icon
177
Merck
MRK
$322B
$30.4M 0.2%
350,024
-12,145
-3% -$998K
ARNA
178
DELISTED
Arena Pharmaceuticals Inc
ARNA
$30.2M 0.2%
665,583
FRPT icon
179
Freshpet
FRPT
$3.04B
$30.1M 0.2%
509,275
-45,553
-8% -$2.43M
CVX icon
180
Chevron
CVX
$382B
$30M 0.2%
248,736
+30,362
+14% +$3.58M
CMS icon
181
CMS Energy
CMS
$23.3B
$29.8M 0.2%
474,500
-345,400
-42% -$21.5M
EVOP
182
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$29.7M 0.2%
1,124,737
ZBRA icon
183
Zebra Technologies
ZBRA
$13.5B
$29.4M 0.2%
115,125
-23,675
-17% -$5.54M
KSU
184
DELISTED
Kansas City Southern
KSU
$29.3M 0.2%
191,175
-21,750
-10% -$3.19M
CUZ icon
185
Cousins Properties
CUZ
$5.31B
$29.3M 0.2%
710,072
-49,475
-7% -$1.94M
TXN icon
186
Texas Instruments
TXN
$248B
$28.7M 0.19%
223,896
-7,236
-3% -$893K
EXPE icon
187
Expedia Group
EXPE
$36.5B
$28.6M 0.19%
264,067
+221,642
+522% +$26M
SNV
188
DELISTED
Synovus
SNV
$28.6M 0.19%
728,400
-25,825
-3% -$949K
BHVN
189
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$28.4M 0.19%
521,817
-168,600
-24% -$8.35M
DOCU
190
DocuSign
DOCU
$11.1B
$28.1M 0.19%
379,250
-369,475
-49% -$25.4M
CHGG icon
191
Chegg
CHGG
$116M
$27.7M 0.19%
731,621
-306,374
-30% -$10.7M
KMT icon
192
Kennametal
KMT
$2.56B
$27.3M 0.18%
740,978
-150,000
-17% -$5.02M
OGS icon
193
ONE Gas
OGS
$5.01B
$27.3M 0.18%
292,116
-51,575
-15% -$4.72M
OC icon
194
Owens Corning
OC
$11B
$27.3M 0.18%
418,850
+164,225
+64% +$10.5M
EPR icon
195
EPR Properties
EPR
$4.89B
$27.2M 0.18%
384,474
-116,500
-23% -$8.59M
COHR icon
196
Coherent
COHR
$43.4B
$27M 0.18%
801,073
-5,000
-0.6% -$159K
TSN icon
197
Tyson Foods
TSN
$21.5B
$26.9M 0.18%
295,507
+11,975
+4% +$1.03M
YETI icon
198
Yeti Holdings
YETI
$3.87B
$26.9M 0.18%
773,146
-270,754
-26% -$8.53M
EYE icon
199
National Vision
EYE
$1.76B
$26.8M 0.18%
827,873
-40,203
-5% -$1.11M
AMZN icon
200
Amazon
AMZN
$2.44T
$26.8M 0.18%
290,000
-4,000
-1% -$354K

Similar funds

Carillon Tower Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Carillon Tower Advisers held 499 positions worth $15B, up 4.3% from $14.4B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Carillon Tower Advisers withdrew a net $689M in Q4 2019, closing 34 positions and reducing 287 holdings. Its most notable exit was Insulet, an estimated $86.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in Seagen Inc. Common Stock worth $48.8M.

  • Carillon Tower Advisers's largest Q4 2019 buy was Seagen Inc. Common Stock: 426,867 shares worth $48.8M.
  • Carillon Tower Advisers added most to Corpay in Q4 2019, an estimated $58.8M increase.
  • Carillon Tower Advisers's biggest Q4 2019 reduction was WEC Energy, cutting an estimated $49.5M.
  • Carillon Tower Advisers fully exited Insulet in Q4 2019, selling an estimated $86.4M.
  • Carillon Tower Advisers's ten largest holdings make up 9.9% of its $15B portfolio in Q4 2019.
  • Carillon Tower Advisers opened 33 new positions and closed 34 in Q4 2019.
  • Carillon Tower Advisers's portfolio value rose 4.3% quarter-over-quarter to $15B.

Based on Carillon Tower Advisers's 13F filing for Q4 2019, filed 11 Feb 2020.